1.gif (1892 bytes)

Original Articles

Indian Pediatrics 2000;37: 939-946

Krabbe Disease - Clinical Profile


Milind S. Tullu, Mamta N. Muranjan, Pratima P. Kondurkar and
Burjor A. Bharucha*

From the Genetics Division, Department of Pediatrics, Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai 400 012, Maharashtra, India.

* Deceased
Reprint requests: Dr. Mamta N. Muranjan, 3rd Floor, 16-B, Naushir Bharucha Marg, Tardeo, Mumbai 400 007, India. E-mail: [email protected]

Manuscript received: December 28, 1999; Initial review completed: February 8, 2000; 
Revision accepted: April 13, 2000.

Objective: To study clinical features and investigations of children with Krabbe Disease (KD). Design: Retrospective. Setting: Genetic Clinic of a tertiary care teaching hospital. Methods: Hospital records of patients with enzymatically confirmed KD were analyzed with respect to their clinical features and investigations including neuroimaging (CT-scan and/or MRI). Galactocerebrosidase (GALC) activity was estimated photometrically in the peripheral blood leukocytes. Results: Nine children (age ranging from 2½ months to 8 years) were studied, of which 5 had the classical infantile disease, 3 had late infantile form and one was diagnosed as juvenile KD. GALC levels in peripheral blood leukocytes were low or absent in all. Most of the children with infantile disease presented with neurodegeneration, seizures or fever. Optic atrophy was uncommon in our series (present only in a single case). Majority of the cases had elevated cerebrospinal fluid (CSF) protein levels and peripheral neuropathy on nerve conduction (NC) studies. Findings typical of KD were noted in 7 patients who underwent magnetic resonance imaging (MRI). The sole patient with juvenile disease presented with developmental delay and progressive spastic quadriparesis. Conclusion: Krabbe disease should be considered in the differential diagnosis of early infantile onset of neurodegeneration with seizures. Likewise, older children with progressive ataxia or spastic quadriparesis in whom the etiology remains obscure, must be investigated for Krabbe disease. MRI can be diagnostic in absence of availability of enzyme diagnosis.

Key words: Galactocerebrosidase, Globoid cell leukodystrophy, Krabbe disease.

Leukodystrophies are a group of rare inherited neurometabolic disorders resulting from defects in the synthesis or catabolism of myelin. Those with an early infantile onset include – Krabbe disease (KD) or globoid cell leukodystrophy (GLD), Pelizaeus-Merzbacher disease, Canavan disease, and Alexander disease. KD is a rare autosomal recessive disorder resulting from the deficiency of the lysosomal enzyme, galactocerebrosidase (GALC) which catabolises degradation of several galactolipids such as galactosylceramide, galactosylsphingosine and galactosyldi-glyceride(1). Early as well as late infantile forms of the disease are well known, but juvenile and adult onset disease are now being increasingly reported. Clinical and radiological manifestations in these age groups are hetero-geneous and the clinician should be aware of these differences. There is no data on KD from India following a MEDLINE search from 1985 to 1999. We present a series of 9 cases of enzy-matically confirmed KD with emphasis on the clinical spectrum, neuroimaging and enzyme diagnosis.

  Patients and Methods

Hospital records of children diagnosed to have KD over a period of 2 years at the Genetic Clinic of a tertiary care teaching hospital in Mumbai were reviewed. Demographic data, clinical features and results of investigations (including neuroimaging) were recorded. GALC activity in peripheral blood leukocytes was assessed photometrically(2) and the values were compared with those obtained from age matched controls. All the samples and controls were tested for the enzyme Aryl sulfatase-A to ensure quality control. TNPAL-galactocerebro-side (115 nmol), 0.5 mg crude sodium tauro-cholate and 60 mg oleic acid in 25 mmol citrate buffer at pH 4.5 was used as substrate.

  Results

Nine children (7 females, 2 males) identified on the basis of clinical features and investigations as possible KD, had low levels of GALC in their leukocytes. Based on the age of onset of the disease and clinical presentation, 5 patients had the classical infantile form of the disease, 3 belonged to the late infantile group and a single case who presented at 8 years of age was diagnosed to have the juvenile form of KD.

Infantile KD

Of the total 8 cases (5 classical and 3 late infantile types), 6 were females and 2 were males. Mean age at presentation was 9.4 months with a range of 2.5 to 21 months. The clinical features are summarized in Table I. Consanguinity was absent in all the cases. Cases 2, 4 and 5 had affected (though undiagnosed) siblings. Diag-nostic protocol in these cases included cerebro-spinal fluid (CSF) analysis, nerve conduction (NC) studies, neuroimaging (CT scan and/or MRI) and GALC assay in peripheral blood leukocytes. Table I gives the results of these investigations. EEG was done in 3 cases (Case 1, 6 and 8) and was abnormal in Case I (showing left temporo-parietal epi-leptiform transients) and Case 8 (showing left sided paroxysmal activity and subcortical epileptogenic activity with solitary right burst). Additional investigations done in isolated cases included brainstem evoked response audiometry (BERA) (Case 1) and visual evoked potentials (VEP) (Case 5) which were normal. None of the cases were available for follow up except Case 1 who was admitted for bronchopneumonia and subse-quently died at 7½ months of age.

TABLE 1–Clinical Features and Investigations in Infantile Krabbe Disease.

 
  Case1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
Case 8
1.
Age of onset (mo)
4
2.5
2.5
3
5
13
15
5
2.
Sex
F
F
F
F
M
F
M
F
3.
Chief complaints
Seizures
ND (motor &
mental)
Seizures
Delayed MS
Fever
Seizures
ND(motor &
mental)
Fever
Seizures
ND(motor &
mental)
Fever
ND(motor &
mental)
ND (motor &
mental)
ND (motor &
mental)
Seizures
Delayed MS
4.
Anthropometry
               
 
Weight (kg)
9(95th%ile)
2.8(<5th%ile)
5.6(<5th%ile)
3.6(<5th%ile)
6.7(5th%ile)
11(75th%ile)
8.5(<5th%ile)
6.2(<5th%ile)
 
Height (cm)
68(50th%ile)
53(5th%ile)
61(<5th%ile)
54(<5th%ile)
67(25th%ile)
85(>95th%ile)
82(25th%ile)
66(<5th%ile)
 
Head circumference
(cm)
41(10th%ile)
37(<5th%ile)
39.5(<5th%ile)
38(<5th%ile)
44(75th%ile)
43(<5th%ile))
47.5(25th%ile)
44(5-10th%ile)
5.
General features
Hypertelorism
Microcephaly
Umbilical
hernia
Contractures
-
Hypertelorism
Low set ears

-
Microcephaly
Hypertelorism
Low set ears
Hyperextensible
joints
Hypertelorism
Hypertelorism
Retrognathia
High arched
palate
6.
Fundus
Normal
Normal
Optic atrophy
Normal
Normal
Normal
Normal
Normal
7.
Tone
Reduced
Increased
Increased
Decreased
Increased
Normal
Increased
Increased
8.
Deep tendon reflexes
Normal
Exaggerated
Absent
Absent
Depressed
Exaggerated
Exaggerated
Exaggerated
9.
Neonatal reflexes
Absent
Present
Absent
Present
Present
Present
Present
Absent
10.
Leukocyte GALC
level (nmol/h/mg 
protein)
Control value-2 to 8
nmol/h/mg protein
0.06
0.005
00
00
00
0.003
00
00
11.
CT Scan - Brain
-
-
-
-
Bilateral
cerebral white
matter
hypodensities,
increased
density of
basal ganglia
and thalami
Bilateral
periventricular
white matter
hypodensities
-
-
12.
MRI (Brain)
Retarded
myelination of
cerebral
hemispheres
and deep white
matter of
cerebellum
-
Bilateral
abnormalities in
cerebral white
matter, basal
ganglia, pons
and both
cerebellar
hemispheres
-
Diffuse
bilateral
symmetrical
involvement
of cerebral
white matter,
corticospinal
tracts & deep
cerebellar
white matter
Bilateral
hyperintense
cerebral white
matter with
corticospinal
tract and
cerebellar
white matter
involvement
Altered signal
in deep white
matter in
bilateral
cerebral
hemispheres
and
descending
corticospinal
tracts
Prominent
fronto-temporo-
parietal cortical
sulci along with
significant delay
in myelination 
13.
Demyelinating
peripheral
neuropathy on NC
studies
Present
-
Present
Present
Present
Absent
-
Present
14.
CSF proteins
(mg/dl)
85
90
65
-
500
25
-
140
ND = Neurodegeneration; MS = Milestones; %ile = Percentile.

Juvenile KD

An 8-year-old female was born of a non-consanguineous marriage with normal antenatal and birth history. She had delayed mental and motor milestones since the age of 18 months. On general examination, her weight was 20.5 kg (5th-10th percentile), height was 112 cm (<5th percentile) and head circumference was 48.5 cm. The developmental quotient was 11 months. Hypertelorism, flat feet and knee joint flexion contractures were noted. Central nervous system examination revealed spastic quadriparesis with depressed deep tendon reflexes. Plantars were flexor in response and there were no cerebellar signs.

Relevant investigations were as follows: Leukocyte GALC level was undetectable, MRI (brain) showed white matter involvement (Figs. 1 & 2), NC studies revealed a diffuse demyelinat-ing sensorimotor neuropathy, audiometry showed bilateral sensorineural hearing loss and VEP was normal.

Fig. 1. T2 weighted axial MR image in Juvenile Krabbe disease, Bilateral symmetric hyperintense signal is seen in the posterior limb of the internal capsule (arrow) and the periventricular white matter (arrow head). Thalami appear hypointense. Fig. 2. Juvenile Krabbe disease : T2 weighted axial MR image shows ill-defined diffuse hyperintense signal within the pons (arrow) and the cerebellar white matter (arrow head).

 

  Discussion

Globoid cell leukodystrophy (GLD) or Krabbe disease (KD) owes its name to the globoid cells (which are characteristic storage cells) found infiltrating around cerebral blood vessels. In his report in 1916, Krabbe described this disease as ‘diffuse cerebral sclerosis’(3). Though the metabolic nature of the disorder was recognized in the late fifties, the etiological basis was established later by Suzuki and Suzuki in 1970 following the demonstration of GALC deficiency in the tissues of affected patients(4). The gene has been cloned and localized to the q21-q31 region of chromosome 14(1). The molecular basis of the disease has been recently established by the identification of a number of mutations and an attempt is being made to establish a genotype-phenotype correlation(5).

A simple classification takes into account the age at onset of the disease and reflects the variations in clinical presentations of the subtypes(6). The classical infantile form mani- fests in the first six months of life with neurodegeneration, failure to thrive, fever, seizures and visual loss. Initial hypotonia gives way to spasticity. As a rule, death occurs by 2 years of age. As opposed to this, a more protracted course with onset of gait disturbances in the second year of life, progressive spasticity and visual loss are characteristics of the late infantile form of the disease. Pyramidal weakness and blindness predominate in the juvenile form, whereas adult onset disease is characterized by slowly progressive ataxia or spasticity with preservation of intellect(7). Hypertelorism though not a feature of KD, was seen in 6 out of 9 cases in our study. Investigations too reflect the dissimilarities between the various subtypes– CSF analysis with raised proteins and NC studies demonstrating peripheral neuropathy are the hallmarks of infantile and sometimes juvenile disease, but adult onset disease is rarely if ever characterized by peripheral neuropathy and raised CSF proteins(6-8).

In the absence of confirmatory evidence of low or absent GALC levels, the characteristic distribution of lesions and MRI signal patterns on T2-weighted images can be diagnostic. Invove-ment of pyramidal tracts, parieto-occipital white matter, posterior corpus callosum, and cerebellar white matter involvement as well as lesions of deep grey matter and cerebral atrophy may be seen(9).

Prior to availability of an enzyme assay, definitive diagnosis was based on histopatho-logical demonstration of globoid cells by brain biopsy. This pathognomonic PAS-positive cell of monocytic origin contains tubular crystalloid aggregates on electron microscopy(1). The demonstration of needle-like inclusions and splinter shaped structures in eccrine sweat glands of axillary skin specimens by electron micro-scopy provides a relatively non-invasive and safe alternative to brain or nerve biopsy(10,11). GALC assay for the diagnosis is expensive and not widely available. Enzyme estimation in cultured skin fibroblasts or peripheral blood leukocytes accurately identifies homozygotes, but its value in heterozygote detection is limited(12). Mutation analysis could prove to be vital in identifying the hetero-zygotes(13,14).

Therapy for KD in the early stages with hematopoietic stem cell transplantation has been successfully attempted with radiological and clinical improvement(15). Retrovirus-mediated gene transfer is found to correct the enzyme deficiency experimentally and holds promise as futuristic therapy(16). At present, counseling and prenatal diagnosis (by enzyme estimation from cultured amniocytes, skin fibroblasts or fetal tissues like brain, kidney, and liver) are the only management strategies that can be offered(17). Of note, has been the successful engraftment after in-utero bone marrow transplant in an affected fetus(18).

In conclusion, the specturm of KD varies from a rapidly progressive disease in infancy with a fatal outcome to a more benign course with gait disturbances in adolescents and adults. In our series, children selected on basis of suggestive clinical symptoms demonstrated the characteristic features of KD on neuroimaging; all proved to have undetectable or low levels of GALC in peripheral blood leukocytes. Diag-nosis by enzyme estimation is not yet available at most of the centers specializing in neuro-metabolic disease in India. In this situation, neuroradiologic features on MRI can be relied upon to establish the diagnosis.

  Acknowledgements

The authors thank Dr. R.G. Shirahatti, Dean, Seth G.S. Medical College and KEM Hospital, Mumbai, for granting permission to publish this article. The authors also thank Dr. Meher Ursekar, Consulting Radiologist, Bombay Hospital, Mumbai, for her help in reporting of the MRI scans.

Contributors: MST participated in data collection, analysis and drafting the paper. MNM participated in data collection and drafting the paper and will act as guarantor for the paper. PPK participated in the enzyme analysis of all the cases and helped in drafting the paper. BAB was instrumental in the diagnosis and investigations of the cases reported.

Funding: None.
Competing interests: None stated.

Key Messages

  • Krabbe Disease (KD) should be considered in the differential diagnosis of infantile neurodegeneration with seizures when accompanied by visual loss. 
  • Adolescents and adults with undiagnosed spastic paraparesis or ataxia should be tested for deficiency of galactocerebrosidase (GALC) especially when the nerve conduction studies are suggestive of peripheral neuropathy. 
  • Neuroimaging can provide a valuable clue to the diagnosis of KD in the absence of availability of GALC enzyme assay. 
  • Being an autosomal recessive disorder, counseling, carrier detection and prenatal diagnosis play a vital role in the management of KD.

  References
  1. Jesionek-Kupnicka D, Majchrowska A, Krawczyk J, Wendorff J, Barcikowska M, Lukaszek S, et al. Krabbe diseas: An ultra-structural study of globoid cells and reactive astrocytes at the brain and optic nerves. Folia Neuropathol 1997; 35: 155-162.

  2. Besley GTN, Gatt S. Spectrophotometric and fluorimetric assays of galactocerebrosidase activity, their use in the diagnosis of Krabbe's disease. Clinica Chimica Acta 1981; 110: 19-26.

  3. Dunn HG, Lake BD, Dolman Cl, Wilson J. The neuropathy of Krabbe's infantile cerebral sclero-sis (globoid cell leucodystrophy). Brain 1969; 92: 329-344.

  4. Suzuki Y, Suzuki K. Krabbe's globoid cell leukodystrophy: Deficiency of galactocerebro-sidase in serum, leukocytes and fibroblasts. Science 1971; 171: 73-75.

  5. Fu L, Inui K, Nishigaki T, Tatsumi N, Tsukamoto H, Kokubu C, et al. Molecular heterogeneity of Krabbe disease. J Inherit Metab Dis 1999; 22: 155-162.

  6. Farrell DF, Swedberg K. Clinical and biochemical heterogeneity of globoid cell leukodystrophy. Ann Neurol 1981; 10: 364-368.

  7. Verdru P, Lammens M, Dom R, Elsen AV, Carton H. Globoid cell leukodystrophy: A family with both late infantile and adult type. Neurology 1991; 41: 1382-1384.

  8. Crome L, Hanefeld F, Patrick D, Wilson J. Late onset globoid cell leucodystrophy. Brain 1973; 96: 841-848.

  9. Loes DJ, Peters C, Krivit W. Globoid cell leukodystrophy: Distinguishing early-onset from the late-onset disease using a brain MR imaging scoring method. Am J Neuroradiol 1999; 20: 316-323.

  10. Ohno I, Shinoda K, Tsugawa K, Takizawa N. Taniguchi N, Kimura S. Electron microscopic finding of eccrine sweat gland epithelial cells in a patient with Krabbe disease. Acta Pediatr Jpn 1995; 37: 507-509.

  11. Ceuterick C, Martin JJ. Krabbe globoid cell leukodystrophy. Electron microscopy shows characteristic inclusions in eccrine sweat glands. Pathol Res Pract 1993; 189: 384-386.

  12. Wenger DA. Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease. APMIS 1993; 40 (Suppl): 81-87.

  13. Rafi MA, Luzi P, Zlotogora J, Wenger DA. Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum Genet 1996; 97: 304-308.

  14. Luzi P, Rafi MA, Wenger DA. Characterization of the large deletion in the GALC gene found in patients with Krabbe disease. Hum Mol Genet 1995; 4: 2335-2338.

  15. Krivit W, Shapiro EG, Peters C, Wagner JE, Cornu G, Kurtzberg J, et al. Hematopoietic stem cell transplantation in globoid-cell leuko-dystrophy. N Engl J Med 1998; 338: 1119-1126.

  16. Gama Sosa MA, de Gasperi R, Undevia S, Yeretsian J, Rouse SC 2nd, Lyerla TA, et al. Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer. Biochem Biophys Res Commun 1996; 218: 766-771.

  17. Ida H, Rennert OM, Watabe K, Efo Y, Maekawa K. Pathological and biochemical studies of fetal Krabbe disease. Brain Dev 1994; 16: 480-484.

  18. Bambach BJ, Moser HW, Blakemore K, Corson VL, Griffin CA, Noga SJ, et al. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant 1997; 19: 399-402.

 

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription